Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010935
Filing Date
2025-05-15
Accepted
2025-05-15 16:15:48
Documents
65
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 780614
2 EX-31.1 ex31-1.htm EX-31.1 15956
3 EX-31.2 ex31-2.htm EX-31.2 16145
4 EX-32.1 ex32-1.htm EX-32.1 7218
5 EX-32.2 ex32-2.htm EX-32.2 7539
  Complete submission text file 0001641172-25-010935.txt   4518729

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rnxt-20250331.xsd EX-101.SCH 40666
7 XBRL CALCULATION FILE rnxt-20250331_cal.xml EX-101.CAL 47886
8 XBRL DEFINITION FILE rnxt-20250331_def.xml EX-101.DEF 141973
9 XBRL LABEL FILE rnxt-20250331_lab.xml EX-101.LAB 332969
10 XBRL PRESENTATION FILE rnxt-20250331_pre.xml EX-101.PRE 252367
67 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 576043
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 25953386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)